Search
Search
Close this search box.

50 Bipartisan Lawmakers Demand DOJ Addresses Growing Number of Chinese-Run Illegal Growth Operations

The US Department of Justice (DOJ) is being called upon to divulge information regarding the alarming rise of illegal cannabis cultivation operations associated with Chinese nationals across the country.

In August last year, a group of lawmakers from Maine sent an initial letter to the DOJ asking it to address the sharp rise in illegal cultivation operations run by Chinese nationals.

According to reports at the time, 270 Chinese-run illegal growth operations worth an estimated $4.37bn were found in Maine.

Now a follow-up letter addressed to Attorney General Merrick Garland, has been penned by a bipartisan cohort of 50 members of congress from numerous states to address these concerns.

The letter  expresses deep concern about the involvement of Chinese organized crime in the illicit cultivation of cannabis within the US. It specifically seeks information on the DOJ’s efforts to investigate the Chinese Communist Party’s role, the extent of awareness regarding unlicensed marijuana farms, the impact of state legalization on these operations, and the potential redirection of revenue from CCP-funded farms to China.

“We write to follow-up to our August 23, 2023, letter regarding reports of a memo that was produced and circulated by Border Patrol officials over alleged illegal Chinese marijuana growing operations in the state of Maine,” the letter said.

“Since that time, there have been multiple raids across the state; since the beginning of this year, police have arrested eight people and seized more than 4,400 cannabis plants at four growing sites in Belgrade, China, and Cornville, Maine.”

The DOJ has until February 23 to respond to the seven questions posed in the letter.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?